Protein structure has never played a more important part in understanding biology than it does today. The power of modern structural methods, and the speed with which structures can be determined, are complemented by the increasing sophistication of molecular biology and biochemical methods for generating tractable proteins and protein complexes. In this section, we see examples of the different kinds of contributions that structural biology and crystallography, in particular, can make. On the one hand, the mechanism of action of a particular protein can be dissected in exquisite atomic detail, with obvious applications to drug development. Beautiful examples of protein--protein complexes also reveal the transient interactions that govern signalling pathways. On the other hand, the extraordinary expansion of the field allows new patterns to emerge from comparing large numbers of protein structures --- for example, in the discovery of unexpected evolutionary relationships. Increasingly, examples arise whereby structural research is ahead of the biology and can pose fundamental functional questions. Finally, there are also phenomena that challenge the very principles of protein structure and make us look anew, as in the case of prions. Above all, structural biology brings the excitement of discovery and the beauty of detail.

Viruses are arguably the simplest of organisms. They also exist in prodigious numbers and can evolve at spectacular rates. Recent outbreaks of new species of viral diseases, such as SARS (severe acute respiratory syndrome), and the continuing threat of new pandemics have emphasised just how much there is to understand and how urgently --- the spread of avian influenza, with its potential for spawning a 1918-like human epidemic, is one worrying example. Two reviews on viruses in this section offer complementary perspectives. The first, on their evolution, is a highly relevant and important topic that, however, presents formidable conceptual challenges. Because sequence relationships in virus proteins are usually undetectable, [Bamford, Grimes and Stuart](10.1016/j.sbi.2005.10.012) have investigated the problem of defining evolutionary lineages by using careful and detailed structural comparisons. There are now a substantial number of viral proteins in the Protein Data Bank and, using these, the authors have identified three virus families whose patterns of infection span the three animal kingdoms. This finding, of course, was anticipated for the picornaviruses. Its challenge rests, however, in the fact that the fundamental problem of lineage needs to be reconciled with the immensely plastic character of viral and bacterial genomes, and the extent of the exchange between viral and host genes.

The second review, most appropriately from China, is by [Bartlam, Yang and Rao](10.1016/j.sbi.2005.10.004). It provides an update on the currently available structural knowledge on the SARS proteins and nucleic acid. As with BSE (bovine spongiform encephalopathy), the outbreak of SARS generated alarm, and raised scientific, social and political issues. The disease is caused by a new virus, from the coronavirus family, referred to as SARS-CoV. These days, the central importance of structural knowledge in analysing and understanding the nature of the biological processes in a disease-causing organism is recognized. In keeping with the research capabilities now possessed by many structural biology laboratories, major programmes were quickly established in several countries, devoted to determining and characterizing the three-dimensional structures, mechanisms and functions of the SARS proteins and macromolecules. The authors review progress with the structural nucleocapsid (N) and spike (S) proteins, various other proteins (including a protease) and a segment of a highly conserved RNA element from the viral genome. Such research has already identified potential ligand-binding sites that are clearly candidates for the possible development of specific anti-viral drugs. This response of the structural community to the arrival of a disease was seen also when HIV appeared in the 1980s, although, in this case, research agencies in the UK and USA were also involved in specifically funded programmes. Close links with the virology, cell biology and, especially, the chemistry communities were crucial then, and that will be true in this situation with SARS as well.

In contrast to viruses, higher animals have developed complex levels of regulation, involving networks of interacting proteins. Three reviews focus on such processes. The first addresses the histone proteins that complex with DNA in chromatin. These are subject to an extraordinary array of post-translational chemical modifications (methylation, acetylation, sumoylation, phosphorylation, etc.), which remodel chromatin and thus regulate gene expression. What goes on must come off, however, and [Holbert and Marmorstein](10.1016/j.sbi.2005.10.006) discuss newly emerging data on the structure and function of the deacetylases and demethylases that remove these groups from histone lysine and arginine residues. Structural data on these enzymes have been sought for years, because of their key roles in cell development, and the structures bring long-awaited mechanistic detail. Some of the chemistry is truly unusual and has the added interest that the small-molecule reaction products can themselves trigger further changes to chromatin. Not surprisingly, because aberrant remodelling of chromatin is associated with malignancies and a variety of age-associated diseases, these enzymes are of great therapeutic interest.

Within a functioning cell, cargo proteins and lipids are transported between organelles in a crowded environment that challenges the requirements of specificity and controlled chemistry. The small GTPases are well-characterised and ubiquitous enzymes that act in the cell as molecular switches that convert GTP to GDP; they are key to many cell signalling processes. When charged with GTP, they switch on their associated pathways and, when bound to GDP, their associated pathways are closed down. The article by [Kawasaki, Nakayama and Wakatsuki](10.1016/j.sbi.2005.10.015) reviews the present state of play with Arf and Rab GTPases, which are involved in the critically important (aren't they all!) complex processes of vesicle formation, fusion and transport. The Arf family is key to the assembly of coat proteins during vesicle formation, whereas the Rab family of GTPases is recruited in the GTP-bound state to membranes, where they regulate vesicular tethering/fusion events. It is possible to make generalisations about the Arf and Rab effectors, in particular the common features of their GTPase-binding sites: these appear to correlate nicely with functional behaviour and to explain crosstalk between pathways. One important component of this area of research, revealed by the review, is the impressive success in obtaining crystals of functional complexes of these enzyme systems and analysing them so speedily. This has made possible the striking progress in defining mechanism and functional relationships described in the review and illustrated graphically in the final schematic.

Another fundamental cellular process is apoptosis (programmed cell death). The 'Bcl-2 inhibitable' pathway in mammals, discussed here by [Hinds and Day](10.1016/j.sbi.2005.10.003), depends on a balance between pro-apoptotic and pro-survival proteins. Cell death is effected by cysteine proteases called caspases. These are held in check by pro-survival proteins, such as Bcl-2, which prevent the cascade of events that leads to caspase activation. In this sense, cells are "primed for death". At first sight, the array of pro-apoptotic and pro-survival proteins has a bewildering complexity, but [Hinds and Day](10.1016/j.sbi.2005.10.003) clarify this nicely by drawing a comparison with the much simpler *Caenorhabditis elegans* system; single proteins in the latter are replaced by families of proteins in the mammalian system. Intriguing features of the latter are that a homologous family can include both pro-survival and pro-apoptotic members, and that many of the molecular recognition events involve a common mechanism of helices binding in grooves. Conformational changes, often involving the movement of helices, are critical. Despite the challenges posed by multidomain proteins and subtle molecular recognition processes, the potential of this system as a therapeutic target is shown by the development of inhibitors of pro-survival proteins, which could induce tumour cells to commit suicide.

Some human pathogens have learnt to take advantage of these same regulatory pathways. The type III secretion system (TTSS) of Gram-negative bacterial pathogens, reviewed by Johnson, Deane and Lea, presents a remarkable example. The TTSS forms a needle assembly, through which effector proteins are injected into the unlucky host. The effector proteins are extremely varied, often of unknown function and can disrupt host signalling networks --- some, in fact, resemble host proteins. The TTSS is a fascinating but difficult subject for structural analysis, but, as the authors point out, it has stimulated some innovative solutions --- including the use of cognate chaperones to generate tractable complexes. Exciting progress has been made on all fronts, including the needle assembly proteins, the specific chaperones that usher effector proteins into the assembly (through which they pass in a partially or completely unfolded state) and some of the effector proteins themselves. The base of the assembly resembles the bacterial flagellum and, like the latter, is falling to the combined assault of crystallography and electron microscopy. Questions remain to be answered, particularly concerning the tip that inserts into the host cell membrane, but this is a rapidly moving story and we eagerly await the next instalment.

The ability of structural biology to generate new functional hypotheses is nicely illustrated by [Ingraham and Redinbo](10.1016/j.sbi.2005.10.009) in their review of orphan nuclear receptors. Classical nuclear receptor proteins form a direct signalling system in which the binding of hormones or metabolites to a ligand-binding domain (LBD) controls DNA binding by a DNA-binding domain (DBD) and, thus, gene expression. Structural analyses of orphan nuclear receptors (those without a known ligand) illustrate the full spectrum of ways in which structure can illuminate function. The size of the ligand-binding pocket varies enormously, with some having no pocket at all and others having very large pockets with the ability to adjust to different-sized ligands. In several proteins, the crystal structures revealed quite unexpected bound ligands. The relevance of such ligands to true physiological function has to be rigorously evaluated, but at the very least they generate new ideas on function and specificity. Changes in surface features suggest how ligand binding may be signalled to activation functions, but one major challenge remains: determining the structure of an intact, full-length receptor. That will make a splash!

A second example of a well-known protein family that proves to have new members whose functions are unknown, or are surprisingly different, is the glutathione *S*-transferase (GST) family, reviewed here by [Oakley](10.1016/j.sbi.2005.10.005). The GSTs are an extremely widespread family whose classical activity is in detoxification, which is achieved through the formation of glutathione conjugates. Their common fold has a conserved mode of binding glutathione, with different subclasses arising through the varied second substrates they bind and through varied modes of activation. As described here, however, new members of the family are emerging, including several transcription factors (one of them the yeast prion protein Ure2p), enzymes involved in prostaglandin biosynthesis and even a soluble protein that undergoes a redox-mediated structural change into a membrane channel protein. Although some of these bind glutathione, giving a functional link, others do not, leaving one to wonder what aspect of the structure has been used in their new functions. Given the importance of glutathione as a cellular redox agent in most living systems, it is likely that this family will grow substantially as more genomes are sequenced and their protein products characterised.

Finally, the outbreak of mad cow disease or BSE brought into scientific focus a new, and initially mysterious, kind of infection. It emerged that a protein now called the prion (proteinaceous infectious particle) was responsible for the condition, and that its infectious mechanism resulted from its propensity to denature and form insoluble fibres. A number of disease conditions referred to as transmissible spongiform encephalopathies (TSEs) are now recognized to be prion based --- for example, scrapie in sheep, Creutzfeldt--Jakob disease (CJD) and the BSE infection transmitted to humans (new variant CJD). The prion\'s native or cellular state (PrP^c^) is soluble and its three-dimensional structure is known. It is the development of its fibrous state (PrP^Sc^, where Sc represents scrapie, the condition in sheep), or an intermediate state of soluble oligomers, that is responsible for transmission. The pathway between PrP^c^ and PrP^Sc^, and the structure of the fibre are not really understood, although there is progress, as the review by Eghiaian reports, most particularly for the yeast system, in which the prion (e.g. Sup35) has a defined and inherited function.

In yeast, understanding prion function is coupled with the ability to insert fibrous prion directly into the organism, making it possible to characterize the relationship between sequence, fibre structure and phenotype. By contrast, the structural study of prions in animals has been beset by ignorance of this abundant glycoprotein\'s function and the inaccessibility of its amyloid fibres to structural analysis. More hopefully, *in vitro* experiments to explore infective mechanism are looking possible. One of the central debates in the prion field concerns the structure and organization of the mammalian prion amyloid fibre, part of a wider debate about the structural nature of amyloid protein. In this context, the structure of the sheep PrP^c^ epitope that is detected in PrP^Sc^ shows that there is strong evidence that complete unwinding of the protein does not occur in this fibre. The crystal structure of the β-strand amyloid fibrils from Sup35 'GNNQQNY' peptides reveals how β strands can give stability to amyloid structures, illustrating at the same time the beauty and the importance of detail in understanding biological processes!
